Aspira Women's Health Inc
F:CUL1

Watchlist Manager
Aspira Women's Health Inc Logo
Aspira Women's Health Inc
F:CUL1
Watchlist
Price: 4.05 EUR Market Closed
Market Cap: €34m

Wall St Price Targets

CUL1 Price Targets Summary
Aspira Women's Health Inc

There are no price targets for CUL1.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Aspira Women's Health Inc Competitors:
Price Targets
558
LK Technology Holdings Ltd
160% Upside
XO
Exotic Food PCL
-26% Downside
TEL
TE Connectivity Ltd
16% Upside
VIBHA
Vibhavadi Medical Center PCL
6% Upside
BC
Brunello Cucinelli SpA
16% Upside
PXS
Pyxis Tankers Inc
98% Upside

Revenue
Forecast

16% / Year
Past Growth
59% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
16% / Year
Past Growth
59% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 6 years is 59%.

Gross Profit
Forecast

12% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss
12% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 1 year is 3%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CUL1's stock price target?
Not Available

CUL1 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Aspira Women's Health Inc?
Projected CAGR
59%

Over the last 14 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 6 years is 59%.

What is the Gross Profit forecast for Aspira Women's Health Inc?
Projected CAGR
3%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 1 year is 3%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett